title: Targeted sequencing of JRFendost003P1
design: "Targeted sequencing was performed using the MSK-IMPACT platform, targeting all exons of 341 'actionable' and cancer genes using custom oligonucleotides (Nimblegen SeqCap)."
attributes.tag: alignment_software
attributes.value: bwa